EICHORCondition: Follicular Lymphoma · Sponsor: University of Liverpool
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to determine whether R-FC is more beneficial that R-CVP in the treatment of older patients (aged 60 or over) with Follicular Lymphoma (FL).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Aberdeen Royal Infirmary | Aberdeen, United Kingdom | — |
| Ysbyty Gwynedd | Bangor, United Kingdom | — |
| Birmingham Heartlands | Birmingham, United Kingdom | — |
| Royal Bournemouth Hospital | Bournemouth, United Kingdom | — |
| Bradford Royal Infirmary | Bradford, United Kingdom | — |
| Frenchay Hospital | Bristol, United Kingdom | — |
| Queen's Hospital, Burton | Burton-on-Trent, United Kingdom | — |
| Addenbrookes Hospital | Cambridge, United Kingdom | — |
| Kent and Canterbury Hospital | Canterbury, United Kingdom | — |
| Velindre Hospital | Cardiff, United Kingdom | — |
| Countess of Chester | Chester, United Kingdom | — |
| Leighton Hospital | Crewe, United Kingdom | — |
+ 61 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01303887